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Developing an accurate empirical
correlation for predicting
anti‑cancer drugs’ dissolution
in supercritical carbon dioxide
Fardad Faress1, Amin Yari2, Fereshteh Rajabi Kouchi3, Ava Safari Nezhad4,
Alireza Hadizadeh5,6, Leili Sharif Bakhtiar7*, Yousef Naserzadeh8 & Niloufar Mahmoudi8
This study introduces a universal correlation based on the modified version of the Arrhenius equation
to estimate the solubility of anti-cancer drugs in supercritical carbon dioxide (CO2). A combination
of an Arrhenius-shape term and a departure function was proposed to estimate the solubility of
anti-cancer drugs in supercritical CO2. This modified Arrhenius correlation predicts the solubility of
anti-cancer drugs in supercritical CO2 from pressure, temperature, and carbon dioxide density. The
pre-exponential of the Arrhenius linearly relates to the temperature and carbon dioxide density, and
its exponential term is an inverse function of pressure. Moreover, the departure function linearly
correlates with the natural logarithm of the ratio of carbon dioxide density to the temperature.
The reliability of the proposed correlation is validated using all literature data for solubility of anticancer drugs in supercritical CO2. Furthermore, the predictive performance of the modified Arrhenius
correlation is compared with ten available empirical correlations in the literature. Our developed
correlation presents the absolute average relative deviation (AARD) of 9.54% for predicting 316
experimental measurements. On the other hand, the most accurate correlation in the literature
presents the AARD = 14.90% over the same database. Indeed, 56.2% accuracy improvement in the
solubility prediction of the anti-cancer drugs in supercritical CO2 is the primary outcome of the current
study.
Supercritical is a technical phrase to refer to operating conditions where both pressure and temperature are
higher than their critical values for a given s ubstance1. It is widely accepted that supercritical fluids (SCF) pose
some valuable advantages over traditional solvents (liquid-like density, gas-like transport properties, low surface
tension, and good mass transfer capacity)2. These characteristics have drawn attention to the SCFs as solvent
media for supercritical extraction/purification purposes in a wide range of a pplications1. Carbon dioxide ( CO2)
is likely the most trustful supercritical fluid in e nergy3, food4, pharmaceutical5,6, and bioactive agent delivery7–10
applications. Indeed, the non-toxic, inflammable, and non-explosive nature of supercritical carbon dioxide
(SCCO2) is responsible for these trustful applications2. Furthermore, the SCCO2 critical characteristics are mild
(temperature = 31.1 °C, pressure = 73.8 bar)11, it is recyclable, simply available at low expense, and covers the
real-field requirement2.
The SCCO2 has outstanding applications in pharmaceutical manufacturing processes12,13. Drug solubility
in SCF is the most crucial information for the feasibility study, development, and construction of the pharmaceutical processes utilized the supercritical fluids as solvent m
 edia14. Since cancer is a leading cause of human
15–18
death all around the w
 orld
, researchers experimentally measured the solubility of different anti-cancer drugs
in supercritical C
 O2, including sorafenib t osylate19, sunitinib m
 alate20, azathioprine21, busulfan22, tamoxifen23,
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letrozole24, tamsulosin25, capecitabine26, paclitaxel27, 5-fluorouracil27, thymidine27, and decitabine28. Unfortunately, the laboratory measurement of drug solubility in supercritical CO2 at whole ranges of pressures and
temperatures is time-consuming and requires high economic e xpenses2.
In order to resolve these operating and economic problems, different thermodynamic-based models (known
as the equation of state)29–32, intelligent p
 aradigms14, predictive m
 odel33,34, and empirical c orrelations35–44 are proposed to simulate different phenomena, including estimating solids solubility in S CCO2. Sodeifian et al. compared
the accuracy of the Peng-Robinson (PR), Soave–Redlich–Kwong (SRK), and available empirical correlations for
predicting solubility of sorafenib t osylate19, sunitinib m
 alate20, and a zathioprine21 anti-cancer drugs in S CCO2.
Performances of the PR equation of state, statistical associating fluid theory of variable range (SAFT-VR), and
six empirical correlations for predicting tamsulosin solubility in supercritical C
 O2 have also been c ompared25.
Generally, the estimation methods of drug solubility in the SCCO2 using the equations of state (EoS) are often
mathematically complicated2, require high computations e fforts2, need relatively high entry information2,45,46,
provide high levels of uncertainty19, and may sometimes fail20. More precisely, they need the operating conditions, critical properties, and also drug characteristics to deliver their p
 redictions19,20.
14
The least-squares support vector m
 achines , artificial neural n
 etworks47–50, quantitative structure–property
relationships51, adaptive neuro-fuzzy inference systems52,53, wavelet transform54–57, and dynamic simulation58–60
are some of the approaches may be used for estimating the solid solubility in supercritical carbon dioxide. Utilizing these intelligent paradigms is only possible when their structure, adjusted hyper-parameters, and performed
pre-processing and post-processing stages be completely a vailable61–65. Despite an acceptable accuracy of these
intelligent methods, some parts of their information are often missed to present, and it is hard or even impossible to be used by other researchers.
The empirical correlations that only need temperature, pressure, and pure SCCO2 density to predict solid
solubility in supercritical carbon dioxide29–32 have attracted greater attention in this regard. In order to escape
an unnecessary repetition, the mathematical expressions of these empirical correlations will be reviewed in the
subsequent sections (see “Most widely used correlations for drug solubility in SCCO2”). The mathematical formulations of these empirical correlations are simple, understandable, ready to use, and their accuracy is often far
better than the thermodynamic-based m
 odels19,20. Moreover, it is possible to incorporate them in an appropriate
optimization algorithm to determine the operating condition that maximizes the drug solubility in S CCO2.
The current research briefly reviewed ten well-known and reliable empirical correlations for estimating solid
solubility in supercritical C
 O235–44. After that, a universal approach based on the modified Arrhenius model is
introduced to relate the anti-cancer drug solubility in S CCO2. This universal approach added a departure function
to the Arrhenius-shape term to estimate the anti-cancer drug solubility in S CCO2. The predictive performance
of the modified Arrhenius model and available correlations in the literature is compared using all available
experimental data for solubility of anti-cancer drugs in S CCO2. 316 experimental data for solubility of sorafenib
tosylate19, sunitinib m
 alate20, azathioprine21, busulfan22, tamoxifen23, letrozole24, tamsulosin25, capecitabine26,
paclitaxel27, 5-fluorouracil27, thymidine27, and d
 ecitabine28 in S CCO2 are used to perform this comparison. The
results show that the modified Arrhenius model improves the previously achieved accuracy in the literature by
more than 56.2%.

Materials and methods

The first part of this section presents the available experimental measurements for the solubility of anti-cancer
drugs in supercritical CO2. The second part reviews the most well-known empirical models for correlating
the solid solubility in SCCO2 to the independent variables (pressure, temperature, and pure supercritical CO2
density).

Anti‑cancer drugs.

As mentioned earlier, cancer is approved as the leading cause of human death
 orldwide15. Therefore, all aspects of anti-cancer drugs, including their solubility in the supercritical CO2 are
w
an exciting research topic for both academic and manufacturing purposes. Based on our best knowledge, the
solubility of only twelve anti-cancer drugs in the supercritical carbon dioxide were measured up to now. These
anti-cancer drugs are sorafenib t osylate19, sunitinib m
 alate20, azathioprine21, busulfan22, tamoxifen23, letrozole24,
25
26
27
tamsulosin , capecitabine , paclitaxel , 5-fluorouracil27, thymidine27, and decitabine28. Table 1 separately
reports the range of pressure, temperature, supercritical C
 O2 density, and anti-cancer drug solubility for all the
laboratory-scale studies. Furthermore, the numbers of available measurements in each research are also shown
in this table.

Most widely used correlations for drug solubility in SCCO2. The developed empirical correlations by
Chrastil35, Jouyban et al.36, Kumar and Johnstone37, Garlapati and Madras38, Bian et al.39, Bartle et al.40, MéndezSantiago and T
 eja41, Sodeifian et al.42, Tan et al.43, and Gordillo et al.44 are widely used to estimate drug solubility
in supercritical carbon dioxide. It should be mentioned that some of these correlations were initially proposed
for the prediction of the solid (not specifically drug) solubility in SCCO2. However, researchers preserved their
mathematical forms, readjusted their coefficients, and modified them to be applied in the drug/SCCO2 phase
equilibria modeling19,25,26,28.
The mathematical formulations of these empirical correlations are given in Table 2. It should be mentioned
that excluding Eq. (1) that predicts the solubility in terms of the mass of solids per volume of the solvent (c2), all
other considered correlations provide the solubility in terms of mole fraction unit ( y2). Furthermore, temperature, pressure, and pure SCCO2 density are designated by T , P , and ρ , respectively. Finally, the coefficients of the
correlations are shown by the a1 to a6 notations.
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CO2 (1) + drug (2)

Temperature (K)

Pressure (MPa)

CO2 density (kg/m3)

Drug solubility* × 106

No. data

308–338

12–27

388–914

0.68–12.57

24

Sunitinib malate20

308–338

12–27

388–914

5–85.6

24

Azathioprine21

308–338

12–27

388–914

2.7–18.3

24

Busulfan22

308–338

12–40

383–971

32.7–865

32

Tamoxifen23

308–338

12–40

383–971

18.8–989

32

Letrozole24

318–348

12–36

319–922

1.6–85.1

20

Tamsulosin25

308–338

12–27

384–914

0.18–10.13

24

Capecitabine26

308–348

15.2–35.4

477–955

2.7–158.8

40

Paclitaxel27

308–328

10–27.5

654–915

1.2–6.2

21

5-Fluorouracil27

308–328

12.5–25

541–901

3.8–14.6

18

Thymidine27

308–328

10–30

325–928

1.2–8

25

Decitabine28

308–338

12–40

383–971

28.4–1070

32

Sorafenib tosylate

19

Table 1.  Literature data for solubility of anti-cancer drugs in supercritical carbon dioxide.

Correlation
Chrastil35
Jouyban et al.36
Kumar and J ohnstone

37

Garlapati and Madras38
Bian et al.39
Bartle et al.40
Méndez-Santiago and Teja
Sodeifian et al.42
Tan et al.43
Gordillo et al.44

41

Formula


c2 = ρ a 1 exp aT2 + a3
 
ln y2 = a1 + a2 ρ + a3 P 2 + a4 P T + a5 TP + a6 ln (ρ)
 
ln y2 = a1 + a2 ρ + aT3
 
ln y2 = a1 + (a2 + a3 ρ) ln (ρ) + aT4 + a5 ln (ρT)


y2 = ρ (a 1 + a 2 ρ) exp aT3 + a4Tρ + a5




y P
ln P2ref = a1 + aT2 + a3 ρ − ρref , Pref = 0.1MPa, ρref = 700 kg/m3


T ln y2 P = a1 + a2 ρ + a3 T
 
2
ln y2 = a1 + a2 PT + a3 ln (ρT) + a4 ρ ln (ρ) + a5 P ln (T) + a6 ln T(ρ)
 
ln y2 = a1 ln (ρT) + a2 ρ + aT3 + a4
 
ln y2 = a1 + a2 P + a3 P 2 + a4 P T + a5 T + a6 T 2

Equation (1)
Equation (2)
Equation (3)
Equation (4)
Equation (5)
Equation (6)
Equation (7)
Equation (8)
Equation (9)
Equation (10)

Table 2.  Available empirical correlations for solute/drug solubility in supercritical carbon dioxide.

Excluding the pure S CCO2 density of the Eq. (3) that is in the kmol/m3 unit, the units of all other variables
are in complete agreement with those unites presented in Table 1.

Results and discussion

This section presents the idea of developing the modified Arrhenius correlation, adjusts its unknown coefficients, and compares its accuracy with other available correlations. The next part of this section is devoted to
the performance analysis of the modified Arrhenius correlation using different graphical methods. Finally, the
modified Arrhenius correlation is employed to monitor the effect of operating conditions on the anti-cancer
drug solubility in S CCO2.

Developing the modified Arrhenius correlation. The massive data processing stages are performed on

the experimental values of solubility of each drug in S CCO2 to reach a general form of the proposed correlation
as follows:

y2 = Arrhenius term + departure function

(11)

Equation (11) states that the anti-cancer drug solubility in the SCCO2 can be accurately estimated by combining an Arrhenius term and a departure function.
At this stage, it is necessary to clarify how the pre-exponential and exponential parts of the Arrhenius term
are related to the influential variables. Then, the departure function incorporates to reduce the deviation between
the Arrhenius term predictions and experimental measurements.
Spearman and Pearson are two well-known relevancy discovery scenarios in the field of data processing62.
They introduce the relevancy between a pair of feature-response variables by a factor in the range of − 1 to + 1.
The minus, zero, and positive factors correspond with indirect dependency, no-relation, and direct dependency, respectively62,66. The strength of either direct or indirect relevancy increases by increasing the magnitude
of factors67. Furthermore, the higher absolute value of the Spearman than the Pearson factor confirms that the
non-linear relationship is stronger than the linear one and vice versa62,66.
Figure 1 exhibits the values of relevancy factor between anti-cancer drug solubility and pressure, temperature,
and pure SCCO2 density. This figure confirms that direct relationships exist between the response and all feature
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Figure 1.  Relevancy between the solubility of anti-cancer drugs in supercritical C
 O2 and temperature, pressure,
and carbon dioxide density.

variables. The anti-cancer drug solubility has the strongest relationship with the pressure and weakest dependency to the temperature. Moreover, since the Pearson factors for temperature and CO2 density are higher than
the Spearman ones, the linear relationship is superior to the non-linear one. The higher Spearman factor than
Pearson for the pressure shows that the anti-cancer drug solubility non-linearly relates to the pressure.
These findings are in complete agreement with the mathematical form of the Arrhenius model. Indeed, the
pre-exponential term can be a function of temperature and C
 O2 density, and the exponential term provides the
non-linear relation with the pressure.
The previous findings specify the linear dependency of the anti-cancer drug solubility on temperature and
CO2 density and its non-linear relationship with the pressure. Figures 2, 3 and 4 are plotted to approve these
findings through visual inspection.
The experimental values of typical anti-cancer drug solubility in the SCCO2 as a function of temperature
are shown in Fig. 2. This figure approves that the temperature dependency of the solubility of the anti-cancer
drugs is almost linear. The departure function is efficiently involved in compensating for the deviation from the
linear relationship.
Since the density of the pure S CCO2 changes by both pressure and temperature, it is impossible to monitor
the dependency of the anti-cancer drug solubility on the C
 O2 density in the two-dimensional graph. Hence,
Fig. 3 depicts the solubility of a typical anti-cancer drug versus the product of pressure and CO2 density. The
linear dependency of the anti-cancer drug solubility on the pure SCCO2 density can be inferred from this figure.
Similar to the temperature, the departure function can compensate for the deviation from the linear relationship
between drug solubility and C
 O2 density.
The semi-logarithm presentation of typical anti-cancer drug solubility in the S CCO2 versus the inverse of
pressure is shown in Fig. 4. This figure approves that the anti-cancer drug solubility in SCCO2 exponentially
relates to the inverse of pressure, i.e., exp (− Ea /P). The observed deviation between the exponential data and
predictions of the Arrhenius term for the pressure effect is then reduced by applying the departure function.
In summary, the following Arrhenius-shape c orrelation68 is inferred to estimate the anti-cancer drug solubility in the SCCO2 (Eq. 12).


Ea
Arrhenius term = f1 (T, ρ) exp −
(12)
P
It is expected that some deviations observe between the Arrhenius term predictions and actual solubility
data. However, it is possible to enhance the accuracy of the Arrhenius-shape model by diminishing the observed
deviations. Therefore, a new term (i.e., departure function) adds to the Arrhenius-shape part to compensate for
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Figure 2.  Dependency of sorafenib tosylate solubility in the supercritical C
 O2 on the isobaric variation of
temperature (the cartesian coordinate).
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Figure 3.  The variation of sorafenib tosylate solubility in the SCCO2 by the solvent density (the cartesian
coordinate).
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Figure 4.  The effect of the inverse pressure on the sorafenib tosylate solubility in the S CCO2 (the semilogarithm coordinate).

this deviation. The observed deviation shows the highest compatibility with the natural logarithm of the CO2
density to the temperature as follows:
 ρ 
departure function = f2 ln
(13)
T
In summary, the general form of the proposed correlation achieves by combining the Arrhenius term and
departure function (Eq. 14).


  ρ 
Ea
+ f2 ln
y2 = f1 (T, ρ) exp −
(14)
P
T
Equation (15) presents the final form of the proposed correlation for estimating the solubility of the anticancer drugs in supercritical C
 O2.
 a 
ρ 
4
y2 = (a1 T + a2 ρ + a3 ) exp −
+ a5 ln
+ a6
(15)
P
T
The pre-exponential part of the Arrhenius term linearly combines the effect of temperature and CO2 density,
while its exponential part is a function of pressure only. The departure function linearly relates to the natural
logarithm of the C
 O2 density to the temperature ratio.
Adjusting the coefficients of the correlations. After determining the general form of the proposed correlation, it
is now necessary to adjust its coefficients using an appropriate method. The differential evolution (DE) optimization algorithm69,70 is employed to adjust these unknown coefficients through a non-linear regression process.
The absolute average relative deviation (AARD%) between the model predictions and actual measurements is an
objective function for the optimization stage. The AARD% formula can be expressed by Eq. (16)71.
  exp

100  y2 − y2cal 
AARD% =
i = 1, 2, . . . , N
(16)
exp
N
y2
i

Table 3 presents the adjusted coefficients for estimating the solubility of different anti-cancer drugs in the
SCCO2.
The literature has already used some correlations (see Table 2) to estimate the anti-cancer drug solubility in
SCCO2. Therefore, the researchers readjusted coefficients and apply them in the drug/SCCO2 systems. However,
readjusting the coefficients of other ones are accomplished in the current study. Supplementary file presents the
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Drug

a1 × 10–6

a2 × 10–6

a3 × 10–6

a4

a5 × 10–6

a6 × 10–6

Sorafenib tosylate

1.4247605573 − 0.0500529210

− 385.827674360

45.3662839688 0

0.349064452

Sunitinib malate

0.2647256734 − 1.4200164959

1355.66373666

36.2840647550 − 12.8796352

0

Azathioprine

0.9468557792 − 0.0163521099

− 266.098396089

24.1069578946 8.36900373

− 4.83860672

Busulfan

60.280909168 − 16.630567159

− 1344.60675047

78.2721455261 76.7145899

0

Tamoxifen
Letrozole

144.11848954

− 42.703480295

8.7649418657 − 2.9569956441

− 1974.01401538

99.6434546809 41.05460792

6.14532671

4.94014077630

80.8669042062 4.145085191

− 0.53838515

Tamsulosin

0.7923204828 0.1478689559

− 368.263373717

Capecitabine

48.093681561 − 12.750147899

− 2037.79351684

35.1646118112 0
123.522295303

2.51134612

17.1813407

− 8.09385756

Paclitaxel

0.0068347581 0.0253752394

− 6.61523852780

14.6087222619 − 22.8448049

17.3239309

5-Fluorouracil

0.5186887168 − 0.1340640969

− 1.39609503380

44.0728502801 − 10.2690278

11.7076100

Thymidine
Decitabine

0.2122407854 0.0094685158
117.68771002

− 10.092201917

− 70.3123673279

18.0254848942 − 2.51330781

3.01138517

− 25,295.9332530

74.7951605316 48.3284747

0

Table 3.  Adjusted coefficients of the proposed correlation for estimating the solubility of anti-cancer drugs in
supercritical CO2.

coefficients of the considered correlations for solubility of all anti-cancer drugs in supercritical C
 O2. The optimization algorithm and objective function like that utilized for the modified Arrhenius model are also employed
to adjust the coefficients of the literature correlations.

Comparative analysis. This section compares the uncertainty in the predictions of the modified Arrhenius
model and available correlations in the literature for solubility of anti-cancer drugs in SCCO2. The prediction
uncertainty of all considered empirical correlations is measured in terms of the AARD% and reported in Table 4.
First of all, it is better to clarify that the highlighted cells (gray color) are calculated in the present study, and the
clean cells are those reported in the literature. As mentioned earlier, the associated coefficients for calculating
this AARD% are presented in Supplementary file. The cells shown by the bold font are the smallest AARD%
(the best results) obtained for estimating a specific anti-cancer drug in supercritical C
 O2. It is obvious that the
modified Arrhenius correlation provides the most accurate results for solubility of six out of twelve anti-cancer
drugs in SCCO2 (i.e., sorafenib tosylate, sunitinib malate, azathioprine, tamsulosin, 5-fluorouracil, thymidine).
On the other hand, the derived correlation by Bian et al.39 predicts the solubility of busulfan, tamoxifen, and
decitabine in supercritical CO2 with the highest accuracy. Finally, the Garlapati and Madras38, Sodeifian et al.42,
and Tan et al.43 correlations provide the most accurate predictions for only one anti-cancer drug.
Figure 5 exhibits the results of ranking analysis on the accuracy of the modified Arrhenius model and available
empirical correlations in the literature for calculating the solubility of different anti-cancer drugs in supercritical
CO2. It can be readily deduced that the proposed correlation in the current study not only presents the most
accurate predictions for six anti-cancer drugs, it also has two second and three third ranks. The worst accuracy of
the modified Arrhenius correlation is associated with capecitabine solubility in the SCCO2 (i.e., the fourth rank).
The proposed correlation by Bian et al.39 with the three first, two second, four third, one fourth, and one ninth
ranks is the next reliable model for the given task. On the other hand, the proposed correlations by G
 ordillo44,
Jouyban et al.36, and Tan et al.43 have the highest levels of uncertainty, respectively.
Overall ranking of the correlation. This section investigates/compares the accuracy of the modified Arrhenius
model and available empirical correlation in the literature for estimating the whole of the database (solubility of
all anti-cancer drugs in supercritical C
 O2). Hence, Fig. 6 illustrates the results of ranking analysis for the overall
accuracy of the considered empirical correlations.
As expected, the modified Arrhenius correlation (with the smallest overall AARD = 9.54%) takes the first ranking place for the whole of the experimental databank. The Bian et al. correlation39 with the overall AARD = 14.90%
is the next accurate model for the given purpose. Generally, all available correlations in the literature have the
AARD% equal to or higher than 14.9%. Indeed, the modified Arrhenius correlation improves the accuracy of
available models in the literature by at least 56.2%.

Performance monitoring of the modified Arrhenius correlation. The agreement between the

experimental solubility data and calculated values by the developed modified Arrhenius correlation is plotted in
Fig. 7. This figure includes the solubility of all anti-cancer drugs in the supercritical carbon dioxide. Despite an
infinitesimal range of the solubility data (~ 10–4), an acceptable compatibility can be observed between actual and
calculated information. The modified Arrhenius correlation provides the R
 2 (regression coefficient, Eq. 17a72) of
0.98479 and standard error of 2.02 × 10–5 for all 316 experimental data.

R2 = 1 −

N 
N 
2 


exp 2
y2exp − y2
y2exp − y2cal /
i=1
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Empirical correlation
Drug

Modified Arrhenius

Chrastil35

Jouyban et al.36

Kumar and
Johnston37

Garlapati and
Madras38

Sorafenib tosylate

7.91

13.9019

14.4019

12.7019

11.0019

Sunitinib malate

3.89

21.26

20

20

38.85

17.1620

Azathioprine

4.29

21

21

8.6221

Busulfan
Tamoxifen

14.20
10.21

16.26

7.41

11.20

22

88.70

7.57

22

12.02

16.5023

96.87

11.1023

16.4023

Letrozole

13.21

22.16

21.5024

39.42

7.1424

Tamsulosin

9.27

22.1125

82.70

15.2025

24.91

Capecitabine

11.42

12.2026

11.9026

10.3026

43.48

Paclitaxel

9.69

28.90

80.95

38.89

11.79

9.88

11.2022

5-Fluorouracil

8.39

19.48

69.90

19.48

22.77

Thymidine

16.64

25.10

91.77

29.86

32.48

Decitabine

9.11

15.3028

88.88

9.0428

15.3028

Overall

9.54

17.42

56.51

18.97

19.64

Empirical correlation
Drug

Bian et al.39

Bartle et al.40

MST41

Sodeifian et al.42

Tan et al.43

Gordillo44

19

Sorafenib tosylate

10.30

13.70

15.30

10.10

52.21

95.85

Sunitinib malate

21.0720

26.1120

24.6820

12.1620

54.69

91.67

Azathioprine

8.4021

12.2221

10.7021

8.0421

13.72

84.91

Busulfan

6.55

11.7022

10.7022

25.99

32.48

96.87

Tamoxifen

8.84

16.1023

16.0023

58.03

45.91

96.87

Letrozole

10.42

46.61

15.4024

26.66

39.20

95.00

Tamsulosin

14.2425

17.0825

16.9825

13.6425

29.07

95.83

Capecitabine

33.00

12.8026

9.9026

41.4726

9.1026

20.5026

19

19

19

Paclitaxel

15.96

50.09

55.31

9.26

18.44

95.23

5-Fluorouracil

15.59

35.34

31.98

13.86

25.52

82.99
96.00

Thymidine

19.68

46.90

40.32

22.31

32.78

Decitabine

8.82

15.3028

13.3028

80.01

49.18

96.88

Overall

14.90

23.24

20.01

30.05

33.19

84.66

Table 4.  Uncertainty of the proposed model and available correlations in the literature in terms of
AARD% (the italicized cells are calculated in the current study; the bold font values show the most accurate
predictions).
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Figure 5.  Outcome of the ranking analysis on the accuracy of the developed correlation and those available in
the literature.
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Figure 6.  Overall ranking of the considered correlations to predict the solubility of anti-cancer drugs in
supercritical carbon dioxide.

Figure 7.  Cross-plot of the modified Arrhenius predictions versus experimental measurements for anti-cancer
drug solubility in supercritical CO2.
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Figure 8.  The observed relative deviations for estimating each experimental measurement of anti-cancer drug
solubility in supercritical carbon dioxide.

Figure 8 investigates the performance of the modified Arrhenius correlation as a function of its relative deviation (RD) for the available database. Equation (17b) expresses the formulation of the RD index73.
 exp

y2 − y2cal
RD =
i = 1, 2, . . . , N
(17b)
exp
y2
i

This figure confirms that the proposed correlation has successfully correlate the experimental solubility data
to its corresponding influential variables. Excluding only three experiments, all other solubility measurements
are estimated with the − 0.5 < RD < 0.5.

Differentiating between outlier/valid data. The focus of this section is concentrated on diagnosis of either valid and suspect data. The experimentally-measured information often contain noises74 and
uncertainties75. The leverage method is used to conduct this analysis76. As Fig. 9 shows, the leverage method
discriminates between the valid (□ symbols) and suspect (○ symbols) information by plotting the standardized
residual (SR) as a function of hat index. The SR can be obtained by dividing the residual error (RE) by its standard
deviation (SD). Equations (18) to (21) present the RE, average value of RE, SD, and SR formula, r espectively77,78.


exp
RE = y2 − y2cal
i = 1, 2, ..., N
(18)
i

N

RE =


1
×
REi
N

(19)

i=1



N
1


2
SD =  ×
RE − RE i
N

(20)

i=1

SR =
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Figure 9.  Differentiating between valid and suspect data collected from the literature.

Applying the leverage method on the experimental databank and estimated values of anti-cancer drug solubility (Fig. 9) justifies that the major segment of the experimental data (92.72%) is valid, and only 23 datasets
may be outliers.
The excellent accuracy of the modified Arrhenius correlation is previously approved using experimental
data and comparison by other available models in the literature. Moreover, the current analysis confirms the
validity of the experimental databank. Therefore, it can be claimed that the modified Arrhenius correlation can
be readily used in the real application.
The numbers of possible outlier for each anti-cancer drug are reported in Fig. 10. It seems that the experimental solubility data for capecitabine, paclitaxel, and 5-fluorouracil with no outlier are the most reliable information.
On the other hand, the solubility measurements of decitabine and tamoxifen (with seven and six outliers) in
SCCO2 are the under-question experiments.

Investigating the effect of operating conditions. It is previously shown in Table 4 that the modified
Arrhenius correlation predict sunitinib malate (AARD = 3.89%) and thymidine (AARD = 16.64%) with the highest and lowest accuracies, respectively. This section investigates the effect of pressure and temperature on the
solubility of these anti-cancer drugs in the SCCO2 both experimentally and modeling.
Figure 11 explains the effect of isothermal variation of the operating pressure on the sunitinib malate in
supercritical carbon dioxide, while Fig. 12 is associated with the thymidine/SCCO2 binary system.
Excluding some scattering data in Fig. 12, generally the solubility of anti-cancer drugs in SCCO2 increase by
increasing either pressure or temperature. This finding is in complete agreement of relevancy analysis (see Fig. 1).
Moreover, an acceptable level of agreement exists between actual solubility data and their associated predictions
by the modified Arrhenius correlation.
A relatively high scattering measurements for thymidine/SCCO2 system (especially at higher temperatures)
is responsible for observed deviation between actual and modeling data. It is worth noting that this is the most
accurate predictions among eleven different empirical correlations (Supplementary Information).
Investigating the effect drug type. By measuring the average value of solubility of different anti-cancer

drugs, it is concluded that busulfan and tamoxifen have the highest tendency for dissolution in supercritical
CO2, while the sorafenib tosylate and tamsulosin show the lowest tendency.
Figures 13 and 14 present the modeling and experimental data for two high-soluble and two low-soluble
anti-cancer drugs in S CCO2, respectively. The provided AARD of 7.92% (busulfan) and 7.40% (tamoxifen) for
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Figure 10.  Numbers of detected outliers for the considered anti-cancer drugs.
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Figure 11.  Variation of the sunitinib malate solubility in the supercritical C
 O2 as a function of operating
pressure and temperature.
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Figure 12.  The effect of pressure and temperature on the thymidine solubility in the supercritical carbon
dioxide.

4.5
4
3.5

10

-4

Busulfan
Tamoxifen
Modified Arrhenius

3
2.5
2
1.5
1
0.5
0
10

15

20

25

30

35

40

Figure 13.  The highest amount of drug solubility in SCCO2 at temperature = 318 K.
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Figure 14.  The smallest amount of drug solubility in S CCO2 at temperature = 318 K.
the high-soluble anti-cancer drugs by the modified Arrhenius correlation is a justification for excellent performance of the model.
On the other hand, the proposed correlation predicts the solubility of the low-soluble anti-cancer drugs with
the AARD of 8.44% (tamsulosin) and 17.92% (sorafenib tosylate).
It should be mentioned that this level of uncertainty for this ultra-low variable (anti-cancer drug solubility
in SCCO2) has its own scientific and real-field merits.

Maximum achievable drug solubility in SCCO2. The previous analysis approved that the busulfan is
the most soluble anti-cancer drug in the supercritical CO2. Therefore, for locating the operating condition that
maximizes the busulfan solubility in the S CCO2, it is necessary to monitor it for all pressures and temperatures.
Figure 15 exhibits the busulfan solubility in SCCO2 for all possible operating conditions from experimental and
modeling perspectives.
Like all other analyses, an excellent performance of the modified Arrhenius correlation can be justified in
this analysis too. This figure also clarifies that the positive effect of pressure on the drug solubility intensifies
by increasing the temperature. In other word, the slope of solubility with respect to the pressure increases by
increasing temperature.
Finally, both experimental data and modeling results show that the highest busulfan solubility in the S CCO2
may be achieved at the highest allowable temperature and pressure (i.e., P = 40 bar, T = 338 K).

Conclusion

A combination of the Arrhenius-shape and departure functions is proposed to correlate the anti-cancer drug
solubility in the supercritical carbon dioxide. The pre-exponential part of the Arrhenius-shape term is linearly
related to the temperature and carbon dioxide density, and its exponential part inversely relates to the pressure.
The departure function is directly related to the natural logarithm of the carbon dioxide density to the temperature ratio. The developed correlation outperformed all well-known literature equations for predicting the solute
solubility in supercritical carbon dioxide. The modified Arrhenius correlation provided the AARD = 9.54% and
R2 = 0.98479 for estimating all experimental datasets in the literature. In contrast, the most accurate correlation
in the literature (i.e., Bian et al. correlation) showed the AARD = 14.90% for predicting the considered database.
It is possible to improve predicting accuracy of anti-cancer drug solubility in supercritical CO2 by more than
56% using the developed correlation in this study. The relevancy analysis exhibited that anti-cancer drug solubility in supercritical C
 O2 increases by increasing either pressure and temperature. Furthermore, it is found that
less than 7.5% of the literature data are suspect information, and the remaining 92.5% are valid measurements.
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Figure 15.  Effect of operating conditions on the busulfan solubility in S CCO2 (open circle: 338 K, open
rectangle: 328 K, six pointed filled star: 318 K, four pointed filled star: 308 K, dashed lines modified Arrhenius
predictions).
The provided Supplementary Material reports the adjusted coefficients of the available empirical correlations
in the literature.

Data availability

All data generated or analyzed during this study are available on reasonable request from the corresponding
author.
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